Burning Mouth Syndrome: Symptoms and Management

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Massachusetts, Amherst

About this trial

This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment, and quality of life.

Eligibility criteria

Qualifiers

Have buring mouth syndrome or experience oral burn

Live in the United States

At least 18 years old

Having been diagnosed or suspected diagnosis of burning mouth syndrome or suffer from chronic oral burn without any identifiable causative lesion

Disqualifiers

Have recently undergone dental treatment in the last three months or have plans to undergo dental treatment (e.g., fillings, crowns, root canals, extractions, or other dental procedures) in the coming month.

Have started any new treatments for BMS in the last 3 months or have plans to start new treatments in the coming month.

Trial design

Treatments tested in this trial

  • Oral cooling spray

Treatment groups

50 Participants
are divided into 1 treatment group